investments-large-investment-17.html
Novo Annual Review 2016
18 / 71
large
investments
in dkk million value at the end of the year investments during the year cash proceeds during the year unrealised and realised returns during the year 31,499 2016 2015 27,774 1,205 703 6,482 -2,146 6,577 2,594 portfolio composition large investments in brief 2016 large investments covers novo a/s? direct investment efforts in well- established life science companies
. these companies are characterised by their strong market position, attractive growth prospects, and an ambitious innovation agenda. large investments was established as a separate entity in 2013. following an extensive strategic review in 2016, this area was highlighted as one where novo will place significant further investments in the years to come. 2 ? medtech 1 ? medical laboratory services 2 ? private majority 3 ? private minority 1 ? bioindustrials 1 ? healthcare it 5 ? pharmaceuticals 5 ? public minority sector allocation by number of companies ownership allocation by number of companies 18 novo a/s 2016
allocation-number-geographical-19.html
